Fort Myers, Fla., September 8, 2022 – — Florida Cancer Specialists & Research Institute, LLC (FCS) is pleased to announce that Board-certified medical oncologist and hematologist Monique Sajjad, DO, a hospitalist with the statewide practice since 2018, is now providing care to patients at the FCS Largo Diagnostic Clinic, located at 1301 2nd Ave. SW, Suite 290, Largo, FL 33770.
Dr. Sajjad received her medical degree from Lake Erie College of Osteopathic Medicine in Bradenton, Florida. She then completed Internal Medicine residency training at the University of Southwest Florida in Tampa and a fellowship in Hematology/Oncology at the H. Lee Moffitt Cancer Center in Tampa.
“Dr. Sajjad is well-known and highly regarded by her colleagues as well as many residents in Pinellas County, having provided care to our patients during their inpatient hospitalizations. We are delighted that she is transitioning to this opportunity with our Largo Diagnostic clinic,” said FCS Chief Executive Officer Nathan H. Walcker.
Michael Diaz, MD, FCS President & Managing Physician, said, “With her experience and exceptional credentials, Dr. Sajjad will assist patients and their families through every stage of their cancer journey with great skill and compassion.”
About Florida Cancer Specialists & Research Institute, LLC: (FLCancer.com)
Recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, Florida Cancer Specialists & Research Institute (FCS) offers patients access to more clinical trials than any private oncology practice in Florida. The majority of new cancer drugs recently approved for use in the U.S. were studied in clinical trials with Florida Cancer Specialists participation.* Trained in prestigious medical schools and research institutes, our physicians are consistently ranked nationally as Top Doctors by U.S. News & World Report.
Founded in 1984, Florida Cancer Specialists has built a national reputation for excellence that is reflected in exceptional and compassionate patient care, driven by innovative clinical research, cutting-edge technologies and advanced treatments, including targeted therapies, genomic-based treatment, and immunotherapy. Our highest values are embodied by our outstanding team of highly trained and dedicated physicians, clinicians and staff.
*Prior to approval
For More Information, Contact:
Michelle Robey, VP of Marketing
Jennifer Bradley, Director of Corporate Communications